F o r P e e r R e v i e w Testing for human papillomavirus and measurement of viral load of HPV 16 and 18 in self-collected vaginal swabs of women who do not undergo cervical cytological screening in Southern France Abstract 3
Cervical cancer is the second leading cause of cancer deaths among women 4 worldwide, with an estimated incidence of 500,000 cases each year and a quarter of 5 a million deaths [Franco et al., 2003 ]. In France, there are more than 3,600 new 6 cases of cervical cancer each year, resulting in more than 1000 deaths per year. 7
Human papillomavirus (HPV) is the major cause of cervical cancer in women. 8
Cytology-based screening ("pap-smear") is the major method of screening for 9 cervical cancer. However, the sensitivity of this method is limited, and the efficacy of Hospital, and stored at -20°C until use. 28
Study population: a pilot sampling campaign was organized in 2 suburbs in the 29 northern part of Marseille, where the rate of low socioeconomic level is high (37,2 to 30 45,5%). The women of low socio-economic level and/or from migrant populations 31 selected for the study were aged 35 to 69years and without a pap smear indexed in 32 the National Insurance Register in the past 2 to 3 years. By individual mailing, the 33 women were randomly either re-invited for a pap smear or invited to perform a self-34 sampling of their vaginal fluid in a medical analysis laboratory close to their home.. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 To quantify the HPV 16 and 18 DNA, a quantitative, duplex real-time (RT)-PCR was 7 performed as previously described [Carcopino et al., 2006 ]. The quantitation plasmid 8 used contained the three target sequences of interest: HPV 16 (on E6 gene), HPV 18 9 (on E7 gene), and human albumin gene (on exon12). The plasmidic solution made it 10 possible to obtain a quantification scale from 10 7 to 1 copy for 5 µl of solution. 11
Positive, negative, and no template controls were introduced in each reaction plate. 12
In the experimental conditions used, the cycle threshold (CT) values for the standard 13 curve of the RT PCR varied from 17 CT (10 7 copies) to 39 CT (1 copy) and the slope 14 varied from -3.0 to -3.2. This allowed a lower detection limit of HPV16 or HPV 18 at 5 15 copies per 5 µl sample. It was established that the samples with a human albumin CT 16 value higher than or equal to 31 (10 2 copies of albumin gene, or 50 human nuclear 17 cells) were excluded from the analysis in order to avoid false negative results. 18
This method allowed HPV 16 and 18 and albumin gene copy number to be quantified 19 in the same assay. So, HPV viral load could be expressed as HPV copies per cell or 20 per million cells. All the specimens were tested by both MY09/MY11 nested PCR and 21 
Preliminary assessment of vaginal swabs 10
Results from vaginal swab versus endocervical brush samples are shown in Table I . 11
Of the 29 participants tested, 12 (41.3%) had CIN1 or CIN2/3 lesions whereas HPV 12 infection was detected in 16 (55%) swab and 17 (58.6%) endocervical brush 13 samples, respectively, by either genotyping or RT-PCR. HPV 16 and 18 DNA loads 14 were comparable in both vaginal swabs and endocervical brush samples (mean HPV 15 16 viral load: 6.5 vs. 6.2 log, p = 0.17; Table I ). For 27 women, HPV types were 16 concordant (12 were concordant positive and 15 negative) in both vaginal swabs and 17 endocervical brush samples (Table II) HPV type 61 while the cervical brush sample was negative (Table I; Table III) . 23
The frequencies of HR-and LR-HPV types are presented in Table III 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 were ≥60-years-old. Of the 120 women sampled, 28 (23.3%) were infected with HPV, 3 and 17 (14.1%) of them harboured HR-HPV types. HR-HPV types most frequently 4 found were HPV-16 (7), 53 (5), 31 (4), 18 (2), 58 (1), and 66 (1) ( Table IV) . 5 LR-HPV types most frequently found were HPV type 6 (6), 61 (5), 70 (2), and 81 (2). 6
Six (21.4%) women were infected with multiple HPV types (≥2) and two of them were 7 infected with HR-HPV types (≥1). HPV types 83 and 84 of undetermined risk were 8 found in 3 women. The median age of HR-and LR-HPV-infected women was 48-9 years-old (range: 37-61; IQR: 39-54 years) and 46-years-old (range: 37-59, IQR: 42-10 54 years), respectively. No differences related to age were found between HR-and 11 LR-HPV-infected women (p=0.6). Among the 17 HR-HPV-infected women, 7 (41.1%) 12
were ≥50-years-old, while 4 (36.3%) of the 11 LR-HPV-infected women were ≥50-13 years-old (p=1.0). As shown in Table V , no age-related differences were found 14 between groups of HPV-uninfected, HR-HPV infected, LR-HPV-infected, and multiple 15 HPV-infected women (p=0.6). The mean HPV 16 load, quantified from 5 women, was 16 6.3 log 10 copies/10 6 cells; the mean HPV 18 load, quantified from 2 women, was 2.4 17 log 10 copies/10 6 cells (Table IV) . HPV 16 DNA loads did not differ significantly with 18 age (p=0.78). No correlation was found between the women's age and their 19 oncogenic viral load by linear regression (r 2 =0, p=0.70). 20
After discovery of the 28 positive DNA tests, 15 women among those harbouring HR-21 HPV types were referred to their physician. Eight women were referred for cytology 22 (4 HPV 16, 1 HPV 18, 3 other HPV types): 1 was abnormal, 5 normal, 2 without 23 information. Among the 17 women harbouring HR-HPV types, six were referred to 24 colposcopy (1 HPV type 18 and 5 other HR-HPV types): two women had high-grade 25 lesions and one had surgery. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 The LR-type most frequently detected was HPV 6 followed by HPV 61, 70, and 81, 7 which is in line with a recent French epidemiological study [Aubin et al., 2008] . 8
In the present study, infection with multiple HPV types was found in 21.4% of HPV-9 infected women, a relatively low rate given that direct sequence analysis detects 10 fewer multiple HPV types than methods such as reverse hybridization methods, 11 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 One of the limitations of the present campaign was the low-response rate to self-4 sampling and follow-up cytology which was related mainly to low socio-economic 5 status and illiteracy; in the next screening campaign, it will be important to determine 6 the actual proportion of women with a persistent infection who have histological CIN-7 2-3 lesions. To this end, a heading requiring the women's telephone number and 8 physician's last name and address has been added to the record form accompanying 9 the self-sampling device. Thus, HR-HPV-infected women will be easily joined by 10 phone and strongly encouraged to follow-up cytology and colposcopy. Moreover, 11
after one year, HR-HPV-infected women will be re-invited to perform again a self-12 sampling. In case of persistent HR-HPV infection, they will receive an information 13 letter inviting them for a suitable follow-up and the non-responders will be joined by a 14 social worker. Another possible limitation of this study was the lack of individual data 15 regarding the socio-economic status of the women contacted, which makes it difficult 16 to determine if the prevalence estimates can be applied to the targeted population. 17
Since collecting individual data is not allowed in France by the National Commission 18
for Information Technology and Civil Liberties, the targeted population was selected 19 in 2 districts of the city with a high deprivation index calculated from census data 20 recorded by the National Institute for Statistics and Economic Studies and from the 21
National Health Insurance. 22
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